Less invasive surfactant administration (LISA)

LISA has been developed as a lung protective strategy for respiratory management and ventilation in view of the mechanical ventilation causing damage to the preterm lungs of newborns.

Infants considered suitable for LISA are those being managed with primary continuous positive airway pressure (CPAP) or high flow with the evidence of increasing respiratory distress and with a rising oxygen requirement.

The regular application of LISA would turn out to be very useful and help save the lives of premature babies.

Leave a Reply